BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 26229150)

  • 21. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
    Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
    Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
    D'Haese J; Theunissen K; Vermeulen E; Schoemans H; De Vlieger G; Lammertijn L; Meersseman P; Meersseman W; Lagrou K; Maertens J
    J Clin Microbiol; 2012 Apr; 50(4):1258-63. PubMed ID: 22301025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
    Avni T; Levy I; Sprecher H; Yahav D; Leibovici L; Paul M
    J Clin Microbiol; 2012 Nov; 50(11):3652-8. PubMed ID: 22952268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
    Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
    Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
    Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
    Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Gupta A; Capoor MR; Shende T; Sharma B; Mohindra R; Suri JC; Gupta DK
    J Lab Physicians; 2017; 9(4):234-238. PubMed ID: 28966482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
    Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of invasive pulmonary aspergillosis: value of bronchoalveolar lavage galactomannan for immunocompromised patients].
    Paugam A; Baixench MT; Lebuisson A; Dupouy-Camet J
    Pathol Biol (Paris); 2010 Feb; 58(1):100-3. PubMed ID: 19892488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
    He H; Ding L; Sun B; Li F; Zhan Q
    Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
    Taghizadeh-Armaki M; Hedayati MT; Moqarabzadeh V; Ansari S; Mahdavi Omran S; Zarrinfar H; Saber S; Verweij PE; Denning DW; Seyedmousavi S
    J Med Microbiol; 2017 Jul; 66(7):898-904. PubMed ID: 28693685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
    Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
    J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
    Russo A; Giuliano S; Vena A; Lucidi C; Falcone M; Raponi G; Merli M; Venditti M
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):83-6. PubMed ID: 24962954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis].
    Zhang XY; Zhao SY; Jiang ZF
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):83-6. PubMed ID: 19573449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.